ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2016 Highlights and Reaffirms Updated Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2016 Highlights and Reaffirms Updated Guidance

ANI Pharmaceuticals (ANIP) PT Lifted to $55 at Guggenheim

May 5, 2016 10:18 AM EDT

Guggenheim analyst Louise Chen reiterating Buy rating and boosted his price target on ANI Pharmaceuticals (NASDAQ: ANIP) to $55.00 (from $50.00) following Q1 beat. The analyst sees many potential catalysts in 2Q16+.

Chen commented, "Post the 1Q16 beat, we remain positive on ANIP and... More

ANI Pharma (ANIP) Tops Q1 EPS by 12c, Offers FY16 Guidance

May 5, 2016 9:29 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $0.76, $0.12 better than the analyst estimate of $0.64. Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.03 million.

GUIDANCE:

ANI Pharma sees FY2016 EPS of $3.54-$3.91, versus the consensus... More